This finding is consistent with previous reports showing that MALT1 protein level is unaffected by treatment with MALT1 protease inhibitors (mepazine or “compound 3”) in DLBCL cells (22, 24). The gene discussed is MALT1; the disease is diffuse large B-cell lymphoma.